Natan Labs

Company Overview

Snapshot

Founded in February 2018 by Rivka Sara Gorban and Alexey Buditskiy, Natan Labs operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing at-home diagnostic technologies.

Business overview

Natan Labs is an R&D-stage company specializing in applied physics med-tech, developing at-home diagnostic technologies. Its core innovation includes a method to separate whole blood into red blood cells, white blood cells, and plasma without the need for a centrifuge or skilled laboratory technician. Additionally, Natan Labs is working on at-home PCR technology that simplifies sample preparation and eliminates the need for skilled laboratory personnel. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving patients globally, with a focus on Europe and North America.

Company Intelligence Q&A

What is Natan Labs' primary focus?

Natan Labs is an R&D-stage company focused on developing at-home diagnostic technologies using applied physics.

Who founded Natan Labs?

Natan Labs was founded by Rivka Sara Gorban and Alexey Buditskiy in February 2018.

What innovative blood separation technology has Natan Labs developed?

Natan Labs has developed a method to separate whole blood into red blood cells, white blood cells, and plasma without requiring a centrifuge or a skilled laboratory technician.

What other diagnostic technology is Natan Labs working on?

Natan Labs is also developing at-home PCR technology that eliminates the need for a skilled laboratory technician and simplifies patient sample preparation.

In which markets does Natan Labs operate?

Natan Labs targets global markets, with a specific focus on Europe and North America, operating within the Health Tech & Life Sciences sector.